(Q43524982)

24 November 2017

title

Toxicity and tolerability of adjuvant breast cancer chemotherapy in obese women (English)

1 reference

24 November 2017

0 references

James P Carroll

1

0 references

Matthew E Cheng

Matthew E Cheng

4

0 references

Melinda Protani

Melinda M Protani

2

0 references

Euan Walpole

Euan Walpole

8

0 references

Jennifer Martin

Jennifer H Martin

9

0 references

author name string

Linda Nguyen

3

1 reference

24 November 2017

Mike Fay

5

1 reference

24 November 2017

Mohamed Saleem

6

1 reference

24 November 2017

Praga S Pillay

7

1 reference

24 November 2017

publication date

19 February 2014

1 reference

24 November 2017

1 reference

24 November 2017

volume

31

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

881

1 reference

Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Relationships between body composition parameters and fluorouracil pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Description of Current Practices of Empiric Chemotherapy Dose Adjustment in Obese Adult Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Dose-response effect of adjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Use of non-anthracycline regimens in early stage breast cancer in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

The cardiac safety of trastuzumab in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Cardiotoxicity profile of trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0881-Z

Simplified calculation of body-surface area.

21 January 2018

1 reference

12 December 2020

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

12 December 2020

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

1 reference

12 December 2020

Doxorubicin clearance in the obese

1 reference

12 December 2020

The calculation of received dose intensity

1 reference

12 December 2020

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

12 December 2020

10.1007/S12032-014-0881-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1006263474

0 references

1 reference